Tapewire

Nasdaq · USD

SERA

SERA PROGNOSTICS, INC.

Export transactions ↓
Tapewire entity
304
SEC CIK
0001534969
Parsed reports
313

Last 12 months

Inside the activity.

0 purchase rows · 52 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 2025013
Jan 202601
Feb 202601
Mar 2026014
Apr 202600
May 202600
Jun 202608
Jul 202600
Aug 202600
Sep 202605
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · derivative · entry 2

CRITCHFIELD GREGORY C · CIK 0001191080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · nonDerivative · entry 1

CRITCHFIELD GREGORY C · CIK 0001191080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 807,270

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000134 · wk-form4_1717792323.xml · derivative · entry 2

Lawrence Sandra AJ · CIK 0001306386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000134 · wk-form4_1717792323.xml · nonDerivative · entry 1

Lawrence Sandra AJ · CIK 0001306386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,117

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC
Trimble RyanDirector
GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000135 · wk-form4_1717792336.xml · derivative · entry 2

Trimble Ryan · CIK 0001871513 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC
Trimble RyanDirector
GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000135 · wk-form4_1717792336.xml · nonDerivative · entry 1

Trimble Ryan · CIK 0001871513 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,117

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000133 · wk-form4_1717792311.xml · derivative · entry 2

Kamdar Kim P. · CIK 0001535065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:32 UTC GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000133 · wk-form4_1717792311.xml · nonDerivative · entry 1

Kamdar Kim P. · CIK 0001535065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,746

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:31 UTC GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000132 · wk-form4_1717792300.xml · derivative · entry 2

Mirza Mansoor Raza · CIK 0001588389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:31 UTC GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000132 · wk-form4_1717792300.xml · nonDerivative · entry 1

Mirza Mansoor Raza · CIK 0001588389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,117

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:31 UTC GrantStock Option (right to buy) · Derivative 10,549 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001534969-24-000131 · wk-form4_1717792288.xml · derivative · entry 2

Barlow Jane F · CIK 0001736026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,549

Underlying: Class A Common Stock · 10,549 shares

Expires 2034-06-06

F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 06, 2024 Filed Jun 7, 2024 20:31 UTC GrantClass A Common Stock 7,117 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000131 · wk-form4_1717792288.xml · nonDerivative · entry 1

Barlow Jane F · CIK 0001736026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,117

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 36,040 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 7

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Catalyst Health Ventures Follow-on Fund, L.P.

Disclosed balance after: 8

F9 · kind: CHV FO distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 5,034 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 6

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,292

F7 · kind: Represents the pro-rata distribution from CHV Investments, and not a purchase or sale, without additional consideration.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 2,297 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 5

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 2,297

F7 · kind: Represents the pro-rata distribution from CHV Investments, and not a purchase or sale, without additional consideration.

F8 · ownership.nature: The shares are held by a living trust, of which the reporting person is a trustee and in which the reporting person has a beneficial interest.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 356,660 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 4

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by CHV Investments, LLC

Disclosed balance after: 17,684

F6 · kind: CHV Investments distributed these shares to its limited members on a pro rata basis, for no consideration.

F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 1,473 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 3

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,258

F4 · kind: Represents the pro-rata distribution from CHV PF, and not a purchase or sale, without additional consideration.

F5 · balance_after: Includes 25,815 shares received as a pro-rata distribution from CHV LP and 1,970 shares received as a pro-rata distribution from CHV PF. In prior reports, the reporting person reported beneficial ownership of 388,622 shares held directly by CHV LP and 166,098 shares held directly by CHV PF.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 156,332 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 2

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Catalyst Health Ventures (PF), L.P.

Disclosed balance after: 9,766

F3 · kind: CHV PF distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 381,869 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 1

Phillips Joshua · CIK 0001871555 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Catalyst Health Ventures, L.P.

Disclosed balance after: 6,753

F1 · kind: Catalyst Health Ventures, L.P. ("CHV LP") distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 2

CRITCHFIELD GREGORY C · CIK 0001191080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,153

F3 · kind: Pro rata distribution from Catalyst Health Ventures (PF) L.P., of which the Reporting Person is a non-managing member.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:35 UTC OtherClass A Common Stock 195 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 1

CRITCHFIELD GREGORY C · CIK 0001191080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,140

F1 · kind: Pro rata distribution from Catalyst Health Ventures, L.P., of which the Reporting Person is a non-managing member.

F2 · balance_after: The Reporting Person purchased 5,000 shares of Class A Common Stock pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2022 to May 31, 2023.

Read SEC document
May 15, 2024 Filed May 15, 2024 22:23 UTC
Kearney PaulChief Data Officer
SaleClass A Common Stock 10,387 $8.24 $85,588.88
Disclosure

SEC source: 0001534969-24-000114 · wk-form4_1715811775.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,300

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.12 to $8.38, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 10, 2024 Filed May 14, 2024 23:16 UTC
Kearney PaulChief Data Officer
Disposition to issuerStock Option (right to buy) · Derivative 44,646 Not disclosed Strike: $0.83 Not disclosed
Disclosure

SEC source: 0001534969-24-000111 · wk-form4_1715728567.xml · derivative · entry 2

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 44,646 shares

Expires 2024-08-20

F1 · price: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest immediately and were granted in exchange for the Reporting Person's agreement to cancel the stock options represented in Table II of this Form 4.

F2 · derivative.exercise_date: The shares subject to this canceled option were fully vested and exercisable.

Read SEC document
May 10, 2024 Filed May 14, 2024 23:16 UTC
Kearney PaulChief Data Officer
GrantClass A Common Stock 40,854 $0.00 $0.00
Disclosure

SEC source: 0001534969-24-000111 · wk-form4_1715728567.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,687

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest immediately and were granted in exchange for the Reporting Person's agreement to cancel the stock options represented in Table II of this Form 4.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:40 UTC
Harrison Robert GardnerChief Information Officer
SaleClass A Common Stock 4,902 $9.59 $47,010.18
Disclosure

SEC source: 0001534969-24-000092 · wk-form4_1715377248.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,795

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:42 UTC
Kearney PaulChief Data Officer
SaleClass A Common Stock 4,205 $9.59 $40,325.95
Disclosure

SEC source: 0001534969-24-000097 · wk-form4_1715377313.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,833

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:41 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 4,902 $9.59 $47,010.18
Disclosure

SEC source: 0001534969-24-000096 · wk-form4_1715377301.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,869

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:41 UTC
Aerts AustinChief Financial Officer
SaleClass A Common Stock 6,592 $9.59 $63,217.28
Disclosure

SEC source: 0001534969-24-000094 · wk-form4_1715377273.xml · nonDerivative · entry 1

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,896

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:41 UTC
Jackson BenjaminGeneral Counsel
SaleClass A Common Stock 4,902 $9.59 $47,010.18
Disclosure

SEC source: 0001534969-24-000095 · wk-form4_1715377287.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,277

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:41 UTC
Lindgardt ZhenyaDirector · Chief Executive Officer
SaleClass A Common Stock 11,992 $9.59 $115,003.28
Disclosure

SEC source: 0001534969-24-000093 · wk-form4_1715377260.xml · nonDerivative · entry 1

Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 896,112

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 28, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 24,474 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · derivative · entry 7

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 24,474 shares

Expires 2024-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 28, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 24,474 $9.04 $221,244.96
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 5

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,771

F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $9.24, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 28, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
Exercise / conversionClass A Common Stock 24,474 $0.91 $22,271.34
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 4

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 48,909 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · derivative · entry 6

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,474

Underlying: Class A Common Stock · 48,909 shares

Expires 2024-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 27, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 48,909 $9.62 $470,504.58
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 3

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,771

F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 27, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
Exercise / conversionClass A Common Stock 48,909 $0.91 $44,507.19
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 2

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2024 Filed Mar 28, 2024 21:56 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 3,753 $9.62 $36,103.86
Disclosure

SEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,771

F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 00:00 UTC
Lindgardt ZhenyaDirector · Chief Executive Officer
SaleClass A Common Stock 38,899 $9.37 $364,483.63
Disclosure

SEC source: 0001534969-24-000065 · wk-form4_1711497606.xml · nonDerivative · entry 1

Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 908,104

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.86, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 00:00 UTC
Aerts AustinChief Financial Officer
SaleClass A Common Stock 8,092 $9.37 $75,822.04
Disclosure

SEC source: 0001534969-24-000064 · wk-form4_1711497592.xml · nonDerivative · entry 1

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,488

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.86, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 26, 2024 Filed Mar 26, 2024 21:38 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 21,438 $9.55 $204,732.90
Disclosure

SEC source: 0001534969-24-000061 · wk-form4_1711489091.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,524

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.17 to $9.83, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 25, 2024 Filed Mar 26, 2024 20:20 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 22,163 $9.10 $201,683.30
Disclosure

SEC source: 0001534969-24-000059 · wk-form4_1711484417.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,962

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:15 UTC
Harrison Robert GardnerChief Information Officer
SaleClass A Common Stock 2,138 $9.02 $19,284.76
Disclosure

SEC source: 0001534969-24-000032 · wk-form4_1709846139.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,697

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:16 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 1,664 $9.02 $15,009.28
Disclosure

SEC source: 0001534969-24-000035 · wk-form4_1709846184.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,125

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:16 UTC
Aerts AustinChief Financial Officer
SaleClass A Common Stock 444 $9.02 $4,004.88
Disclosure

SEC source: 0001534969-24-000034 · wk-form4_1709846171.xml · nonDerivative · entry 1

Aerts Austin · CIK 0001979974 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,580

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:16 UTC
Kearney PaulChief Data Officer
SaleClass A Common Stock 1,028 $9.02 $9,272.56
Disclosure

SEC source: 0001534969-24-000033 · wk-form4_1709846158.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,038

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:15 UTC
Jackson BenjaminGeneral Counsel
SaleClass A Common Stock 1,856 $9.02 $16,741.12
Disclosure

SEC source: 0001534969-24-000031 · wk-form4_1709846125.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,179

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 21:56 UTC
Harrison Robert GardnerChief Information Officer
SaleClass A Common Stock 5,665 $8.03 $45,489.95
Disclosure

SEC source: 0001534969-24-000009 · wk-form4_1707342992.xml · nonDerivative · entry 1

Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,835

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 21:57 UTC
Jackson BenjaminGeneral Counsel
SaleClass A Common Stock 5,665 $8.03 $45,489.95
Disclosure

SEC source: 0001534969-24-000012 · wk-form4_1707343032.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001779964 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,035

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 21:57 UTC
Boniface John J.Chief Scientific Officer
SaleClass A Common Stock 5,665 $8.03 $45,489.95
Disclosure

SEC source: 0001534969-24-000011 · wk-form4_1707343015.xml · nonDerivative · entry 1

Boniface John J. · CIK 0001870674 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,789

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 21:56 UTC
Kearney PaulChief Data Officer
SaleClass A Common Stock 4,984 $8.03 $40,021.52
Disclosure

SEC source: 0001534969-24-000010 · wk-form4_1707343003.xml · nonDerivative · entry 1

Kearney Paul · CIK 0001888075 · Chief Data Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,066

F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.